WNK2 and neoplasm: Platelets contribute to tumor progression through multiple pathways, including the secretion of pro-angiogenic factors (vascular endothelial growth factor, platelet-derived growth factor) (46–48) and the release of microvesicles that activate mitogen-activated protein kinases signaling (49).